Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

In this Healio Video Perspective from the ESCRS winter meeting, Ramza Diamanti, MD, discusses the importance of patient communication when using presbyopia-correcting lenses. Patient lifestyle, ...

TPG-backed ophthalmology specialist BVI Medical will use the investment to fund new product launches and scale its operations ...

EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

The department of Ophthalmology at Father Muller Medical College (FMMC), under the aegis of SKOS and ALCON, successfully ...

Alcon Inc (ALC) reports robust growth with $9.8 billion in revenue and unveils plans for future expansion and shareholder returns.

CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching ... UNITY VCS surgical platform, PanOptix Pro intraocular lens, and the Voyager laser trabeculoplasty ...

Q4 2024 Management View CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching $9.8 billion, a 6% increase, and core diluted EPS growing by 16% to $3.05. Free cash ...

Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, is most implanted IOL in the world. It was the first IOL to be ...

Narrow-moat Alcon reported solid fourth-quarter earnings and ended 2024 on strong footing. Total sales of $2.5 billion were up 7.1% year over year thanks to broad-based growth across the portfolio.

Monofocal IOLs are preferred for patients with glaucoma, macular degeneration, and diabetic macular edema due to their suitability and effectiveness. Patient discussions are crucial for tailoring IOL ...